Entia Biosciences Inc (ERGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,729 | -1,095 | -894 | -683 | -1,266 |
| Depreciation Amortization | 434 | 341 | 268 | 170 | 236 |
| Accounts receivable | -6 | -11 | -13 | -13 | -62 |
| Other Working Capital | 357 | 178 | 213 | 68 | 42 |
| Other Operating Activity | 735 | 402 | 356 | 378 | 526 |
| Operating Cash Flow | $-209 | $-186 | $-69 | $-81 | $-523 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4 | -4 | -4 | -3 | -32 |
| Purchase Sale Intangibles | -40 | -35 | -16 | -8 | -45 |
| Other Investing Activity | -27 | -27 | -11 | -5 | -97 |
| Investing Cash Flow | $-31 | $-30 | $-15 | $-8 | $-129 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 15 | N/A | N/A | N/A | 250 |
| Debt Issued | 15 | 26 | N/A | N/A | 319 |
| Common Stock Issued | 153 | 143 | 43 | N/A | 121 |
| Other Financing Activity | 8 | -11 | -13 | 37 | -21 |
| Financing Cash Flow | $191 | $159 | $30 | $37 | $669 |
| Beginning Cash Position | 65 | 65 | 65 | 65 | 48 |
| End Cash Position | 17 | 8 | 11 | 13 | 65 |
| Net Cash Flow | $-48 | $-57 | $-54 | $-52 | $17 |
| Free Cash Flow | |||||
| Operating Cash Flow | -209 | -186 | -69 | -81 | -523 |
| Capital Expenditure | -4 | -4 | -4 | -3 | -32 |
| Free Cash Flow | -212 | -189 | -73 | -84 | -555 |